[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Mitigation](https://github.com/mm80843/T3.5/tree/main/docs/Mitigation/index.md) >> Individual ID:PBN__Mitigation_882 

# __Testing__

## Category to which it belongs

* [Expansive array of methods, including biomarkers, self-reported symptoms, and AI-powered diagnostics, used for widespread and rapid testing.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_171.md)

## Closest similar item

* [Lack of testing](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_3039.md)
* [Mass testing](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_1.md)
* [Testing strategy limitations](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_3040.md)
* [Invasive individual testing](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_3041.md)
* [Limited testing capacity](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_3042.md)
* [Low testing capacity](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_3043.md)
* [Limited access to testing](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_3044.md)
* [Slow testing process](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_3045.md)
* [Lack of access to testing](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_3046.md)
* [Insufficient testing data](https://github.com/mm80843/T3.5/blob/main/docs/Mitigation/PBN__Mitigation_3047.md)

## Property: has_MitigationPrinciple

Conducting diagnostic testing to identify and detect cases of contagious diseases, including those that may be undetected, to better understand the spread and prevalence of the disease and inform appropriate mitigation measures.

## Risks possibly mitigated by this Mitigation

* [Undetected infections](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2788.md)

## Property: has_MitigationSource

* [Mitigation strategies and compliance in the COVID-19 fight; how much compliance is enough?](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_154.md)
* [Effects of non-pharmaceutical interventions against COVID-19 on the incidence of other diseases](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_30.md)
* [The impacts of knowledge, risk perception, emotion and information on citizens’ protective behaviors during the outbreak of COVID-19: a cross-sectional study in China](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_74.md)
* [Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_101.md)

## This Mitigation is enabled by the following technologies

* [testing kits](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_610.md)
* [diagnostic testing](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_345.md)
* [diagnostic testing kits](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3512.md)
* [laboratory equipment](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3829.md)
* [laboratory facilities](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3513.md)

